-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology FACS Platform: A Comprehensive Analysis of Features and Advantages
Author:
InnoModels
Release time:
2024-06-27
With the rapid development of biotechnology, Flow Cytometry Analysis Sorting (FACS) technology has become an important and indispensable tool in cell research and immunology. With its unique FACS platform, InnoModels Biotechnology (Beijing) Co., Ltd. stands out in the industry, providing researchers with efficient and accurate cell analysis solutions. In this article, we will introduce the features and advantages of the FACS platform of InnoModels Biotechnology in detail.
Features overview:
1. Highly flexible multi-parameter analysis
The InnoModels Biotechnology FACS platform is equipped with highly flexible multi-parameter analysis capability, which enables simultaneous analysis of multiple cell markers in a single experiment through a multi-channel laser and fluorescent label detection system. This comprehensive cell characterization capability enables researchers to gain a deeper understanding of cell properties and functions, providing powerful support for disease diagnosis, treatment and prevention.
2. Wide range of applications
The FACS platform is not only suitable for basic science research, but also widely used in drug development, immunotherapy and clinical diagnosis. Whether it is immunophenotyping, cell cycle research or stem cell research, the platform can provide researchers with precise and efficient solutions. In addition, by collaborating with customers, InnoModels Biotechnology provides customized solutions to meet the needs of different research projects.
3. Accuracy and Stability
The InnoModels Biotechnology FACS platform focuses on data accuracy and instrument stability. Its instruments are designed and manufactured to meet the highest standards to ensure the reliability of experimental results. At the same time, the company provides quality control kits and standard operating procedures (SOPs) to help ensure consistency and reproducibility of experiments. This enables researchers to use the platform with confidence for a variety of cell analysis experiments.

Advantage Analysis:
1. Efficient data processing capability
The InnoModels Biotechnology FACS platform has powerful data processing capabilities that enable it to quickly process and analyze large amounts of cellular data. This high efficiency enables researchers to obtain results faster, thus accelerating the scientific research process.
2. Easy-to-use interface
The platform adopts an intuitive and easy-to-use interface, allowing researchers to get started without special training. At the same time, InnoModels Biotechnology also provides comprehensive customer training and technical support to ensure that users can fully utilize the potential of FACS technology and solve any problems they may encounter in their experiments.
3. Excellent price/performance ratio
The FACS platform of InnoModels Biotechnology has achieved a good balance between performance and price. Its high-performance instruments and reagents, as well as comprehensive service support, make the platform cost-effective and the tool of choice for a wide range of researchers.
To summarize, with its highly flexible multi-parameter analysis, wide range of application areas, both accuracy and stability, as well as efficient data processing capability, easy-to-use interface and excellent price/performance ratio, the FACS platform of InnoModels Biotechnology occupies an important position in the field of biotechnology. With the continuous development of science and technology, it is believed that the FACS platform of InnoModels Biotechnology will be applied in more fields, bringing more convenience and protection to human health and life.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd